Dyer RA, van Dyk D, Dresner A. The use of uterotonic drugs during caesarean section. Int J Obstet Anesth. 2010;19:313-9.

Mortalidade materna no Brasil: principais causas de morte e tendências temporais no período de 1990 a 2010. 2011.

Yamaguchi ET, Cardoso MMSC, Torres MLA. Ocitocina em cesarianas. Qual a melhor maneira de utilizá-la?. Rev Bras Anestesiol. 2007;57:324-30.

Wedisinghe L, MacLeod M, Murphy DJ. Use of oxytocin to prevent haemorrhage at caesarean section - a survey of practice in the United Kingdom. Eur J Obstet Gynecol Reprod Biol. 2008;137:27-30.

Roach MK, Abramovic A, Tita AT. Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. Am J Perinatol. 2013;30:523-8.

Butwick AJ, Coleman L, Cohen SE. Minimum effective bolus dose of oxytocin during elective caesarean delivery. Br J Anaesth. 2010;104:338-43.

Sheehan SR, Montgomery AA, Carey M. Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial. BMJ. 2011;343:d4661.

George RB, McKeen D, Chaplin AC. Up-down determination of the ED90 of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing cesarean delivery. Can J Anaesth. 2010;57:578-82.

King KJ, Douglas MJ, Unger W. Five unit bolus oxytocin at cesarean delivery in women at risk of atony: a randomized, double-blind, controlled trial. Anesth Analg. 2010;111:1460-6.

Tsen LC, Balki M. Oxytocin protocols during cesarean delivery: time to acknowledge the risk/benefit ratio?. Int J Obstet Anesth. 2010;19:243-5.

Frölich MA, Esame A, Warren III WM. High-dose oxytocin is not associated with maternal temperature elevation: a retrospective cohort study of mid-trimester pregnancy with intrauterine fetal demise. Int J Obstet Anesth. 2011;20:30-3.

Thibonnier M, Conarty DM, Preston JA. Human vascular endothelial cells express oxytocin receptors. Endocrinology. 1999;140:1301-9.

The confidential enquiries into maternal deaths in the United Kingdom 1997-1999. 2001.

Langesaeter E, Rosseland LA, Stubhaug A. Hemodynamic effects of oxytocin during cesarean delivery. Int J Gynaecol Obstet. 2006;95:46-7.

Langesaeter E, Rosseland LA, Stubhaug A. Haemodynamic effects of oxytocin in women with severe preeclampsia. Int J Obstet Anesth. 2011;20:26-9.

Archer TL, Knape K, Liles D. The hemodynamics of oxytocin and other vasoactive agents during neuraxial anesthesia for cesarean delivery: finding in six cases. Int J Obstet Anesth. 2008;17:247-54.

Thomas JS, Koh SH, Cooper GM. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing caesarean section. Br J Anaesth. 2007;98:116-9.

McLeod G, Munishankar B, MacGregor H. Maternal haemodynamics at elective caesarean section: a randomised comparison of oxytocin 5-unit bolus and placebo infusion with oxytocin 5-unit bolus and 30-unit infusion. Int J Obstet Anesth. 2010;19:155-60.

Svanström MC, Biber B, Hanes M. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during caesarean section. Br J Anaesth. 2008;100:683-9.

Sartain JB, Barry JJ, Howat PW. Intravenous oxytocin bolus of 2 units is superior to 5 units during elective caesarean section. Br J Anaesth. 2008;101:822-6.

Dyer RA, Reed AR, van Dyk D. Hemodynamic effects of ephedrine, phenylephrine and the coadministration of phenylephrine with oxytocin during spinal anesthesia for elective cesarean delivery. Anesthesiology. 2009;111:753-65.

Pursche T, Diedrich K, Branz-Jansen C. Blood loss after caesarean section: depending on the management of oxytocin application?. Arch Gynecol Obstet. 2012;286:633-6.

Anvisa Medicamentos. .

Rosaeg OP, Cicutti NJ, Labow RS. The effect of oxytocin on the contractile force of human atrial trabeculae. Anesth Analg. 1998;86:40-4.

Carvalho JC, Balki M, Kingdom J. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol. 2004;104:1005-10.

Balki M, Ronayne M, Davies S. Minimum oxytocin dose requirement after cesarean delivery for labor arrest. Obstet Gynecol. 2006;107:45-50.

Balki M, Cristian AL, Kingdom J. Oxytocin pretreatment of pregnant rat myometrium reduces the efficacy of oxytocin but not of ergonovine maleate or prostaglandin F2α. Reprod Sci. 2010;17:269-77.

Yamaguchi ET, Cardoso MM, Torres ML. Serum oxytocin concentrations in elective caesarean delivery: randomized comparison of three infusion regimens. Int J Obstet Anesth. 2011;20:224-8.

Butwick AJ, Gerard W. Ostheimer lecture - what's new in obstetric anesthesia. Int J Obstet Anesth. 2012;21:348-56.

Cordovani D, Balki M, Farine D. Carbetocin at elective cesarean delivery: a randomized controlled trial to determine the effective dose. Can J Anaesth. 2012;59:751-7.

Moertl MG, Friedrich S, Kraschl J. Haemodynamic effects of carbetocin and oxytocin given as intravenous bólus on women undergoing caesarean delivery: a randomised trial. BJOG. 2011;118:1349-56.

Rosseland LA, Hauge TH, Grindheim G. Changes in blood pressure and cardiac output during cesarean delivery: the effects of oxytocin and carbetocin compared with placebo. Anesthesiology. 2013;119:541-51.